Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Completed 48Terminated 13Withdrawn 3Unknown 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1Classical hematology 1

Conditions

Neoplasms 1Fatigue 1Anemia 1

Interventions

Cyclophosphamide 128Cisplatin 119Radiotherapy 111pembrolizumab 110Paclitaxel 96Gemcitabine 96Carboplatin 96Nivolumab 76Magnetic Resonance Spectroscopy 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Doxorubicin 52fludarabine 51Biopsy 48durvalumab 44Cytarabine 44Drug Therapy 43Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Lenalidomide 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Withdrawn × Interventional × Epoetin Alfa × Clear all
NCT00624312 2021-08-06

Procrit Versus Placebo to Determine Efficacy in Pre-Operative Major Surgical Oncology Operations

University of Louisville

Phase 2 Withdrawn
Tumor-Agnostic

Neoplasms

NCT00052221 2018-11-08

Epoetin Alfa in Treating Fatigue in Patients With Advanced Solid Tumors Who Are Not Receiving Chemotherapy

M.D. Anderson Cancer Center

Phase NA Withdrawn

Fatigue

NCT00481624 2018-03-05

Procrit

University of Louisville

Phase 2 Withdrawn
Classical hematology

Anemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡